Atrogi is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, pioneering the development of novel treatments for metabolic disorders.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Atrogi AB →Already a subscriber? Sign in
Xcout Intel tracks Atrogi AB continuously — this profile deepens as new filings, funding, people and hiring data arrive.